News -

Medtech - Private Placement of €9,4 Million in ConceptoMed AS

The Board of Directors of ConceptoMed AS announce the private placement of equity in ConceptoMed AS. Following the share issue, the number of Shareholders in the company amounts to 73 (previously 37). Gross proceeds from the private placement amounts to NOK 89.056.000 (approx. 9,4 MEUR), whereof 25,5 MNOK (approx. 2,7 MEUR) were subscribed by existing shareholders.

ConceptoMed AS stands before an exciting international development of the ground breaking Luer-Jack. This private placement will finance the global market introduction and further growth.

The share issue values ConceptoMed AS at NOK 426 Million (approx. €44,2 Million) post money.

Topics

  • Business enterprise

Contacts

Christian Mide

Press contact CEO +47 95 100720

Related content

LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark)

LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark) FIRST ORDERS OF LUER-JACK SHIPPING AFTER CE-MARK APPROVAL ConceptoMed today announced that the company has received CE Mark approval for the Luer-Jack® syringe, a new and innovative medical syringe. Luer-Jack® is now ready for the European market and other large markets, where the CE mark allows for market entry.

Oversubscribed private placement - total €10,5 Million (100 MNOK) in ConceptoMed AS

The Board of Directors of ConceptoMed AS announce the final completion of the successful private placement of equity in ConceptoMed AS for the period January-February 2016. The placement round was oversubscribed.

ConceptoMed with Global IPR strategy + Dehns​ Patent and Trade Mark Attorneys

Since April 2012, Dehns has drafted and filed over 50 patent applications across 8 families, as well as a number of design registrations and trade marks. Patents have so far been granted in 4 families, and applications are pending in a number of territories including UK & Europe, PCT, USA, Brazil, Argentina, Australia, China, Hong Kong, India, South Korea, Singapore, Japan, Mexico, and Russia.

Luer-Jack featured on Front Page of the Major Norwegian Business Newspaper "Dagens Næringsliv"

Wednesday 27th of January 2016, the Major Norwegian Business Newspaper "Dagens Næringsliv" featured Luer-Jack alongside with strong recommendations from the clinical side in a two-page article.